111 related articles for article (PubMed ID: 19584440)
1. Alzheimer's disease selective vulnerability and modeling in transgenic mice.
Götz J; Schonrock N; Vissel B; Ittner LM
J Alzheimers Dis; 2009; 18(2):243-51. PubMed ID: 19584440
[TBL] [Abstract][Full Text] [Related]
2. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
3. Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology.
Capetillo-Zarate E; Staufenbiel M; Abramowski D; Haass C; Escher A; Stadelmann C; Yamaguchi H; Wiestler OD; Thal DR
Brain; 2006 Nov; 129(Pt 11):2992-3005. PubMed ID: 16844716
[TBL] [Abstract][Full Text] [Related]
4. Neurochemistry of dementia: establishing the links.
Whitehouse PJ; Gambetti P; Harik SI; Kalaria RN; Perry G; Younkin SI; Tabaton M; Unnerstall JR
Prog Clin Biol Res; 1989; 317():131-42. PubMed ID: 2574868
[TBL] [Abstract][Full Text] [Related]
5. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.
Götz J; Streffer JR; David D; Schild A; Hoerndli F; Pennanen L; Kurosinski P; Chen F
Mol Psychiatry; 2004 Jul; 9(7):664-83. PubMed ID: 15052274
[TBL] [Abstract][Full Text] [Related]
6. New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple scales.
Wearne SL; Rodriguez A; Ehlenberger DB; Rocher AB; Henderson SC; Hof PR
Neuroscience; 2005; 136(3):661-80. PubMed ID: 16344143
[TBL] [Abstract][Full Text] [Related]
7. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
[TBL] [Abstract][Full Text] [Related]
8. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
[TBL] [Abstract][Full Text] [Related]
11. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
Tsai SJ
Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
[TBL] [Abstract][Full Text] [Related]
12. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
13. The PDAPP mouse model of Alzheimer's disease: locus coeruleus neuronal shrinkage.
German DC; Nelson O; Liang F; Liang CL; Games D
J Comp Neurol; 2005 Nov; 492(4):469-76. PubMed ID: 16228992
[TBL] [Abstract][Full Text] [Related]
14. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice.
Eckert A; Schindowski K; Leutner S; Luckhaus C; Touchet N; Czech C; Müller WE
Neurobiol Dis; 2001 Apr; 8(2):331-42. PubMed ID: 11300728
[TBL] [Abstract][Full Text] [Related]
16. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
17. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
18. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons.
Mattson MP; Guthrie PB; Kater SB
Prog Clin Biol Res; 1989; 317():333-51. PubMed ID: 2690106
[TBL] [Abstract][Full Text] [Related]
20. Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease.
Härtig W; Stieler J; Boerema AS; Wolf J; Schmidt U; Weissfuss J; Bullmann T; Strijkstra AM; Arendt T
Eur J Neurosci; 2007 Jan; 25(1):69-80. PubMed ID: 17241268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
